Core Viewpoint - The company, Steady Medical, acknowledges the potential benefits of the national fertility subsidy policy for its infant products, particularly under the Purcotton brand, which includes items like diapers and clothing for infants [1] Group 1: Company Products - The company emphasizes its commitment to the development of infant-related products, which include baby wet and dry cotton wipes, Nais baby diapers, and various infant clothing and accessories such as onesies, swaddles, and gauze bath towels [1] - Recent years have seen significant improvements in product design and user experience for the company's infant product line [1] Group 2: Market Context - The national fertility subsidy policy has been clarified to include daily necessities for infants, which may positively impact the sales of the company's products [1]

Core Viewpoint - The company acknowledges the impact of various factors on its stock price fluctuations and emphasizes its commitment to improving operational performance and shareholder value [1] Group 1 - The company responded to an investor inquiry regarding the latest number of shareholders as of August [1] - The management indicated that shareholder information will be disclosed in regular reports, adhering to the principle of fair information disclosure [1] - The company expressed gratitude for the investor's attention and support [1]

Group 1 - The company is actively engaged in the research and development of biomaterials, specifically in collaboration with universities on the "Bionic Artificial Cornea Research and Development Project" [1] - The project has a long research and development cycle and is currently progressing steadily according to the established plan, but has not yet entered the clinical stage [1] - The collagen protein extraction has achieved mass production, but the current impact of collagen products on the company's financial statements is limited [1]

Group 1 - The company is actively engaged in the research and development of bionic artificial cornea materials in collaboration with universities, under the Shenzhen major technology project [1] - The bionic artificial cornea project is currently progressing steadily according to the established plan but has not yet entered the clinical stage [1] - The collagen extraction process has achieved mass production, although the impact of collagen products on the company's financial statements is currently limited [1]

Core Viewpoint - The company is actively engaging in the research and development of advanced biomaterials, specifically collaborating with universities on a significant technology project related to bionic artificial cornea development [1] Group 1: Project Development - The bionic artificial cornea research and development project is a major technology initiative supported by the Shenzhen government [1] - The project has a long research and development cycle and is currently progressing steadily according to the established plan, but has not yet entered the clinical stage [1] Group 2: Product Production - The company has achieved mass production of collagen extraction, although the current impact of collagen products on the group's financial statements is limited [1]

Group 1 - The stock price of Steady Medical reached 40.45 yuan as of August 5, 2025, with an increase of 0.35 yuan from the previous trading day [1] - The trading volume on that day was 46,800 hands, with a transaction amount of 1.89 billion yuan [1] - Steady Medical focuses on healthcare products, with its main business covering medical dressings and health consumer goods, widely used in medical institutions and home care scenarios [1] Group 2 - On August 5, the net outflow of main funds was 6.1651 million yuan, with a cumulative net outflow of 73.253 million yuan over the past five trading days [1] - The current total market value of the company is 23.555 billion yuan, and the price-to-earnings ratio is 23.69 times [1]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 40.88 | 10.01% | 1.66万 | 6795.38万 | | 301009 | 可靠股份 | 14.45 | 4.48% | 14.35万 | 2.05亿 | | 002511 | 中顺洁桑 | 7.77 | 3.05% | 20.93万 | 1.61亿 | | 001328 | 登康口腔 | 44.44 | 2.56% | - 3.23万 | 1.43亿 | | 300658 | 延江股份 | 7.12 | 1.42% | 20.81万 | 1.49亿 | | 301108 | 洁雅股份 | 26.59 | 1.06% | 2.30万 | 6129.21万 | | 300888 | 稳健医疗 | 40.45 | 0.87% | 4.68万 | 1.89亿 | | 001206 | 依依股份 | 25.47 | 0.04% | 4.35万 | 1.11亿 | | 600249 | 两面针 | 5.92 | ...

融券方面，当日融券卖出0.36万股，净买入0.21万股。 来源：金融界 8月4日，沪深两融数据显示，稳健医疗获融资买入额0.26亿元，居两市第1069位，当日融资偿还额0.31 亿元，净卖出536.40万元。 最近三个交易日，31日-4日，稳健医疗分别获融资买入0.30亿元、0.19亿元、0.26亿元。 ...

Group 1 - The stock price of Steady Medical as of August 4, 2025, closed at 40.10 yuan, a decrease of 0.01 yuan or 0.02% from the previous trading day [1] - The trading volume on that day was 61,900 hands, with a transaction amount of 246 million yuan [1] - Steady Medical specializes in medical health products, focusing on the research, production, and sales of medical dressings and protective equipment, with applications in medical institutions and personal care [1] Group 2 - On August 4, the net outflow of main funds was 30.26 million yuan, with a cumulative net outflow of 99.49 million yuan over the past five trading days [1] - The current total market capitalization of the company is 23.351 billion yuan, and the circulating market capitalization is 7.038 billion yuan [1]

证券之星消息，8月4日个护用品板块较上一交易日上涨1.67%，倍加洁领涨。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。个护用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 37.16 | 10.01% | 2.01万 | 7476.70万 | | 605009 | 豪悦护理 | 39.79 | 4.68% | 5.23万 | 2.05亿 | | 001206 | 依依股份 | 25.46 | 3.88% | 5.17万 | 1.30亿 | | 301009 | 可靠股份 | 13.83 | 2.83% | 7.36万 | 1.00亿 | | 600249 | 两面针 | 5.93 | 2.07% | 21.04万 | 1.25亿 | | 603193 | 润本股份 | 33.52 | 1.58% | 13.02万 | 4.40亿 | | 301108 | 洁雅股份 | 26.31 | 1 ...